Ejtahed HS, Soroush AR, Angoorani P, Larijani B, Hasani-Ranjbar S. Gut microbiota as a target in the pathogenesis of metabolic disorders: a new approach to novel therapeutic agents. Hormone and Metabolic Research. 2016; 48(6): 349-58.

Shamarina D, Stoyantcheva I, Mason CE, Bibby K, Elhaik E. Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research. Microbiome. 2017; 5(1):1-9.

Ejtahed HS, Hasani-Ranjbar S, Larijani B. Human microbiome as an approach to personalized medicine. Alternative Therapies in Health and Medicine. 2017; 23(6): 8-9.

Ma Y, Chen H, Lan C, Ren J. Help, hope and hype: ethical considerations of human microbiome research and applications. Protein & cell. 2018; 9(5): 404-15.

Rhodes R. Ethical issues in microbiome research and medicine. BMC Medicine. 2016;14(1):1-4.

Smith HJ. An ethical investigation into the microbiome: the intersection of agriculture, genetics, and the obesity epidemic. Gut Microbes. 2020; 12(1):1760712.

Shin A, Xu H. Privacy risks in microbiome research: public perspectives before and during a global pandemic. Ethics & Human Research. 2022; 44(4): 2-13.

Chuong KH, Hwang DM, Tullis DE, Waters VJ, Yau YC, Guttman DS, et al. Navigating social and ethical challenges of biobanking for human microbiome research. BMC Medical Ethics. 2017;18(1):1-0.

Lange L, Berg G, Cernava T, Champomier-Vergès MC, Charles T, Cocolin L, et al. Microbiome ethics, guiding principles for microbiome research, use and knowledge management. Environmental Microbiome. 2022; 17(1): 1-8.

Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, et al. Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med. 2015; 162: 630–8.

Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016; 165: 609–16.

Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, et al. Successful resolution of recurrent Clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study. Am J Gastroenterol. 2017; 112: 940–7.

Goloshchapov OV, Olekhnovich El, Sidorenko SV, Moiseev IS, Kucher MA, Fedorov DE, et al. Long-term impact of fecal transplantation in healthy volunteers. BMC Microbiol. 2019; 19: 312.

Sachs RE, Edelstein CA. Ensuring the safe and effective FDA regulation of fecal microbiota transplantation. J Law Biosci. 2015; 2: 396–415.

Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: uses, questions, and ethics. Medicine in Microecology. 2020; 6: 100027.

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11: 506-14.

Harrison KL, Farrell RM, Brinich MA, Highland J, Mercer M, McCormick JB, et al. ‘Someone should oversee it’: patient perspectives on the ethical issues arising with the regulation of probiotics. Health Expectations. 2015;18(2): 250-61.

Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E. Spotlight on the compositional quality of probiotic formulations marketed worldwide. Frontiers in microbiology. 2021;12: 693973.